GlassScriptPhysician profile
Matthew D Berke
NPI 1841268885
$6,163.09
in general payments reported to CMS, 2019-2025
48 companies · $694 in 2025
The $694 reported for 2025 was more than what 83% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,672 · 2020: $633 · 2021: $612 · 2022: $1,006 · 2023: $863 · 2024: $682 · 2025: $694.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,219 · Education: $21.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,218.66 |
| Education | $21.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,554.30 | 2019-2025 | Wavewriter Alpha Prime 16, Infinion 16, Superion Indirect Decompression System |
| Forte Bio-Pharma LLC | $569.88 | 2020-2025 | Prolate, Nalocet, Tanlor |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $495.96 | 2019-2025 | Xifaxan, Relistor |
| Scilex Pharmaceuticals INC. | $345.47 | 2019-2025 | Ztlido |
| Collegium Pharmaceutical, INC. | $242.45 | 2019-2025 | Xtampza |
| Biodelivery Sciences International, INC. | $229.51 | 2019-2021 | |
| Assertio Therapeutics, INC. | $223.30 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $191.40 | 2022-2025 | Soliris, Ultomiris |
| Allergan, INC. | $169.41 | 2019-2022 | |
| Arbor Pharmaceuticals, INC. | $165.59 | 2019-2022 | |
| Almatica Pharma LLC | $155.31 | 2021-2023 | Gralise |
| Nevro Corp. | $155.29 | 2019-2023 | Senza |
| Novartis Pharmaceuticals Corporation | $117.40 | 2019 | |
| Abbott Laboratories | $112.22 | 2021-2025 | Proclaim |
| Amgen INC. | $106.37 | 2019-2021 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $103.91 | 2024-2025 | Sprint Pns System |
| Ibsa Pharma INC. | $99.57 | 2021-2024 | Tirosint, Tirosint, Flector |
| Lilly USA, LLC | $98.84 | 2019 | |
| Azurity Pharmaceuticals, INC. | $78.85 | 2023-2024 | Horizant, Horizant |
| Spinal Simplicity, LLC | $71.37 | 2025 | Ha Minuteman G3-R |
| Saluda Medical Americas, INC. | $68.47 | 2023-2025 | Evoke, Evoke Scs |
| Mdd US Operations, LLC | $64.08 | 2019 | |
| Vertos Medical, INC. | $63.95 | 2019-2024 | Mild Device Kit |
| Redhill Biopharma INC. | $58.64 | 2021-2022 | |
| Si-Bone, INC. | $51.91 | 2020-2025 | |
| Pacira Pharmaceuticals Incorporated | $51.87 | 2019-2024 | Zilretta, Iovera |
| Hikma Pharmaceuticals USA | $46.95 | 2021-2023 | Kloxxado |
| Depuy Synthes Sales INC. | $45.74 | 2019-2022 | |
| Daiichi Sankyo INC. | $40.82 | 2019 | |
| Janssen Pharmaceuticals, INC | $39.86 | 2021-2022 | |
| Globus Medical, INC. | $34.57 | 2025 | Senza |
| Grt US Holding, INC. | $28.99 | 2021-2022 | |
| Radius Health, INC. | $28.53 | 2022 | |
| Sanofi-Aventis U.S. LLC | $28.02 | 2019 | |
| Pfizer INC. | $24.61 | 2019 | |
| Shionogi INC | $23.20 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $19.83 | 2019 | |
| Averitas Pharma INC. | $16.81 | 2025 | Qutenza |
| Trevena, INC. | $16.45 | 2023 | Olinvyk |
| Vericel Corporation | $16.08 | 2019 | |
| Eisai INC. | $15.21 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $14.77 | 2019 | |
| Curonix LLC | $14.49 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Idorsia Pharmaceuticals US INC | $13.79 | 2024 | Quviviq |
| Supernus Pharmaceuticals, INC. | $13.38 | 2020 | |
| Zyla Life Sciences, INC. | $12.98 | 2019 | |
| Horizon Therapeutics Plc | $11.88 | 2019 | |
| Mml US, INC. | $10.81 | 2025 | Reactiv8 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Berke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.